CSPC Pharmaceutical Group (HKSE:01093) 3-Year Revenue Growth Rate : 5.40% (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group 3-Year Revenue Growth Rate?

CSPC Pharmaceutical Group's Revenue per Share for the three months ended in Dec. 2023 was HK$0.70.

During the past 12 months, CSPC Pharmaceutical Group's average Revenue per Share Growth Rate was -0.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 11.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was 15.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of CSPC Pharmaceutical Group was 49.30% per year. The lowest was -50.00% per year. And the median was 17.50% per year.

Competitive Comparison of CSPC Pharmaceutical Group's 3-Year Revenue Growth Rate

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CSPC Pharmaceutical Group's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's 3-Year Revenue Growth Rate falls into.

CSPC Pharmaceutical Group 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

CSPC Pharmaceutical Group (HKSE:01093) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

CSPC Pharmaceutical Group 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group (HKSE:01093) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

CSPCY:USA CHJTF:USA CVG:Germany

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (HKSE:01093) Headlines

No Headlines